ArticleDermatology and therapy2026

Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

Steven Daveluy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.